U.S. flag

An official website of the United States government

NM_007194.4(CHEK2):c.252A>G (p.Glu84=) AND Malignant tumor of breast

Germline classification:
Benign (1 submission)
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001356135.10

Allele description [Variation Report for NM_007194.4(CHEK2):c.252A>G (p.Glu84=)]

NM_007194.4(CHEK2):c.252A>G (p.Glu84=)

Gene:
CHEK2:checkpoint kinase 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
22q12.1
Genomic location:
Preferred name:
NM_007194.4(CHEK2):c.252A>G (p.Glu84=)
Other names:
NP_009125.1:p.Glu84=
HGVS:
  • NC_000022.11:g.28734470T>C
  • NG_008150.2:g.12397A>G
  • NM_001005735.2:c.252A>G
  • NM_001257387.2:c.-526A>G
  • NM_001349956.2:c.252A>G
  • NM_007194.4:c.252A>GMANE SELECT
  • NM_145862.2:c.252A>G
  • NP_001005735.1:p.Glu84=
  • NP_001336885.1:p.Glu84=
  • NP_009125.1:p.Glu84=
  • NP_665861.1:p.Glu84=
  • LRG_302t1:c.252A>G
  • LRG_302:g.12397A>G
  • LRG_302p1:p.Glu84=
  • NC_000022.10:g.29130458T>C
  • NG_008150.1:g.12365A>G
  • NM_001005735.1:c.252A>G
  • NM_007194.3:c.252A>G
  • p.E84E
  • p.Glu84Glu
Links:
dbSNP: rs1805129
NCBI 1000 Genomes Browser:
rs1805129
Molecular consequence:
  • NM_001257387.2:c.-526A>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001005735.2:c.252A>G - synonymous variant - [Sequence Ontology: SO:0001819]
  • NM_001349956.2:c.252A>G - synonymous variant - [Sequence Ontology: SO:0001819]
  • NM_007194.4:c.252A>G - synonymous variant - [Sequence Ontology: SO:0001819]
  • NM_145862.2:c.252A>G - synonymous variant - [Sequence Ontology: SO:0001819]

Condition(s)

Name:
Malignant tumor of breast
Synonyms:
Malignant breast neoplasm; Cancer breast
Identifiers:
MONDO: MONDO:0007254; MedGen: C0006142

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001551209Department of Pathology and Laboratory Medicine, Sinai Health System - The Canadian Open Genetics Repository (COGR)

See additional submitters

no assertion criteria provided
Benignunknownclinical testing

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedunknownyesnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Department of Pathology and Laboratory Medicine, Sinai Health System - The Canadian Open Genetics Repository (COGR), SCV001551209.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The CHEK2 p.Glu84Glu variant was identified in 80 of 2744 proband chromosomes (frequency: 0.03) from families with high risk of HBOC and/or Li-Fraumeni-like syndromes and was present in 43 of 1644 control chromosomes (frequency: 0.03) from healthy individuals (Ingvarsson 2002, Mohamad 2015, Novak 2008, Rashid 2013, Ruijs 2009, Sodha 2002, Staalesen 2004, Kilpivaara 2004, Bayasal 2004). In one study the variant co-occurred with a BRCA2 pathogenic variant (Ingvarsson 2002). The variant was also identified in dbSNP (ID: rs1805129) as “With Likely benign” allele, ClinVar (classified as benign by Ambry Genetics, Prevention Genetics, Counsyl, Color Genomics and Invitae; and likely benign by Illumina), Clinvitae (3x benign and 2x likely benign), Zhejiang Colon Cancer Database (7x) and was not identified in Cosmic database. The variant was identified in control databases in 9839 (265 homozygous) of 276942 chromosomes at a frequency of 0.04 (Genome Aggregation Consortium Feb 27, 2017), identified in the following populations at a frequency greater than 1%: East Asian in 1688 of 18848 chromosomes (freq: 0.09), Ashkenazi Jewish* in 864 of 10150 chromosomes (freq: 0.085), African in 1565 of 23956 chromosomes (freq: 0.065), South Asian in 1209 of 30778 chromosomes (freq: 0.039), Other in 201 of 6450 chromosomes (freq: 0.031), European (Finnish) in 733 of 25778 chromosomes (freq: 0.028), European (Non-Finnish) in 3152 of 126566 chromosomes (freq: 0.025), Latino in 427 of 34416 chromosomes (freq: 0.012) increasing the likelihood this could be a low frequency benign variant. The p.Glu84Glu variant is not expected to have clinical significance because it does not result in a change of amino acid and is not located in a known consensus splice site. In addition, in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer, HumanSpliceFinder) do not predict a difference in splicing. In summary, based on the above information this variant meets our laboratory's criteria to be classified as benign.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 26, 2024